Review



silver nanoparticles against e coli atcc  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    ATCC silver nanoparticles against e coli atcc
    Silver Nanoparticles Against E Coli Atcc, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 19 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/silver+nanoparticles+against+e+coli+atcc/Escherichia+coli/pm41730123-423-12-17
    Average 95 stars, based on 19 article reviews
    silver nanoparticles against e coli atcc - by Bioz Stars, 2026-10
    95/100 stars

    Images

    Related Articles

    Diffusion-based Assay:

    Article Title: Synthesis, antibacterial activity and genotoxicity of silver nanoparticles
    Article Snippet: Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224.

    Article Title: NMR Based Real-Time Analysis of Exometabolites Decodes the Mechanism of Action of Antibacterial Molecules, Nanoparticles, and Materials.
    Article Snippet: 2007, 73 (6), 1712−1720. (55) Raffi, M.; et al. Antibacterial Characterization of Silver Nanoparticles against E. Coli ATCC-15224.

    Article Title: Synthesis of Silver nanoparticles using bioactive seaweeds against poultry pathogens
    Article Snippet: Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224.

    Article Title: Novel Investigative Study on the Anticancer Potential of Plant Extracts and Silver Nanoparticles as Inhibitory Agents for Lung Cancer
    Article Snippet: [34] Raffi, M., Hussain, F., Bhatti, T.M., Akhter, J.I., Hameed, A., and Hasan, M.M., Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224.

    Article Title: Plasmon-based detection of Uric Acid in aqueous solution using colloidal Ag nanoparticles
    Article Snippet: Bhatti, et al. Antibacterial characterization of silver nanoparticles against E.coli ATCC-15224.

    Article Title: Atomic force microscopic investigations of transient early-stage bacterial adhesion and antibacterial activity of silver and ceria modified bioactive glass
    Article Snippet: M. Raffi, F. Hussain, T. Bhatti, J. Akhter, A. Hameed, M. Hasan, Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224.

    Article Title: Antibacterial Effect of Myco-synthesized Nano-silver against Multidrug-resistant Bacteria
    Article Snippet: Multidrug resistance bacteria (MDR) are a serious and increasing public health problem.. For controlling pathogen growth, new strategies such as biosynthesized nanoparticles by Fusarium oxysporum extract are urgently needed.. The biosynthesis of silver nanoparticles (AgNPs) as an antibacterial agent against MDR clinical isolates bacteria such as Staphylococcus aureus and Klebsiella pneumonia was determined.

    Inhibition:

    Article Title: Synthesis, antibacterial activity and genotoxicity of silver nanoparticles
    Article Snippet: Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224.

    Article Title: NMR Based Real-Time Analysis of Exometabolites Decodes the Mechanism of Action of Antibacterial Molecules, Nanoparticles, and Materials.
    Article Snippet: 2007, 73 (6), 1712−1720. (55) Raffi, M.; et al. Antibacterial Characterization of Silver Nanoparticles against E. Coli ATCC-15224.

    Article Title: Synthesis of Silver nanoparticles using bioactive seaweeds against poultry pathogens
    Article Snippet: Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224.

    Article Title: Novel Investigative Study on the Anticancer Potential of Plant Extracts and Silver Nanoparticles as Inhibitory Agents for Lung Cancer
    Article Snippet: [34] Raffi, M., Hussain, F., Bhatti, T.M., Akhter, J.I., Hameed, A., and Hasan, M.M., Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224.

    Article Title: Plasmon-based detection of Uric Acid in aqueous solution using colloidal Ag nanoparticles
    Article Snippet: Bhatti, et al. Antibacterial characterization of silver nanoparticles against E.coli ATCC-15224.

    Article Title: Atomic force microscopic investigations of transient early-stage bacterial adhesion and antibacterial activity of silver and ceria modified bioactive glass
    Article Snippet: M. Raffi, F. Hussain, T. Bhatti, J. Akhter, A. Hameed, M. Hasan, Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224.

    Article Title: Antibacterial Effect of Myco-synthesized Nano-silver against Multidrug-resistant Bacteria
    Article Snippet: Multidrug resistance bacteria (MDR) are a serious and increasing public health problem.. For controlling pathogen growth, new strategies such as biosynthesized nanoparticles by Fusarium oxysporum extract are urgently needed.. The biosynthesis of silver nanoparticles (AgNPs) as an antibacterial agent against MDR clinical isolates bacteria such as Staphylococcus aureus and Klebsiella pneumonia was determined.

    Confocal Laser Scanning Microscopy:

    Article Title: Synthesis, antibacterial activity and genotoxicity of silver nanoparticles
    Article Snippet: Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224.

    Article Title: NMR Based Real-Time Analysis of Exometabolites Decodes the Mechanism of Action of Antibacterial Molecules, Nanoparticles, and Materials.
    Article Snippet: 2007, 73 (6), 1712−1720. (55) Raffi, M.; et al. Antibacterial Characterization of Silver Nanoparticles against E. Coli ATCC-15224.

    Article Title: Synthesis of Silver nanoparticles using bioactive seaweeds against poultry pathogens
    Article Snippet: Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224.

    Article Title: Novel Investigative Study on the Anticancer Potential of Plant Extracts and Silver Nanoparticles as Inhibitory Agents for Lung Cancer
    Article Snippet: [34] Raffi, M., Hussain, F., Bhatti, T.M., Akhter, J.I., Hameed, A., and Hasan, M.M., Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224.

    Article Title: Plasmon-based detection of Uric Acid in aqueous solution using colloidal Ag nanoparticles
    Article Snippet: Bhatti, et al. Antibacterial characterization of silver nanoparticles against E.coli ATCC-15224.

    Article Title: Atomic force microscopic investigations of transient early-stage bacterial adhesion and antibacterial activity of silver and ceria modified bioactive glass
    Article Snippet: M. Raffi, F. Hussain, T. Bhatti, J. Akhter, A. Hameed, M. Hasan, Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224.

    Article Title: Antibacterial Effect of Myco-synthesized Nano-silver against Multidrug-resistant Bacteria
    Article Snippet: Multidrug resistance bacteria (MDR) are a serious and increasing public health problem.. For controlling pathogen growth, new strategies such as biosynthesized nanoparticles by Fusarium oxysporum extract are urgently needed.. The biosynthesis of silver nanoparticles (AgNPs) as an antibacterial agent against MDR clinical isolates bacteria such as Staphylococcus aureus and Klebsiella pneumonia was determined.

    Staining:

    Article Title: Synthesis, antibacterial activity and genotoxicity of silver nanoparticles
    Article Snippet: Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224.

    Article Title: NMR Based Real-Time Analysis of Exometabolites Decodes the Mechanism of Action of Antibacterial Molecules, Nanoparticles, and Materials.
    Article Snippet: 2007, 73 (6), 1712−1720. (55) Raffi, M.; et al. Antibacterial Characterization of Silver Nanoparticles against E. Coli ATCC-15224.

    Article Title: Synthesis of Silver nanoparticles using bioactive seaweeds against poultry pathogens
    Article Snippet: Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224.

    Article Title: Novel Investigative Study on the Anticancer Potential of Plant Extracts and Silver Nanoparticles as Inhibitory Agents for Lung Cancer
    Article Snippet: [34] Raffi, M., Hussain, F., Bhatti, T.M., Akhter, J.I., Hameed, A., and Hasan, M.M., Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224.

    Article Title: Plasmon-based detection of Uric Acid in aqueous solution using colloidal Ag nanoparticles
    Article Snippet: Bhatti, et al. Antibacterial characterization of silver nanoparticles against E.coli ATCC-15224.

    Article Title: Atomic force microscopic investigations of transient early-stage bacterial adhesion and antibacterial activity of silver and ceria modified bioactive glass
    Article Snippet: M. Raffi, F. Hussain, T. Bhatti, J. Akhter, A. Hameed, M. Hasan, Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224.

    Article Title: Antibacterial Effect of Myco-synthesized Nano-silver against Multidrug-resistant Bacteria
    Article Snippet: Multidrug resistance bacteria (MDR) are a serious and increasing public health problem.. For controlling pathogen growth, new strategies such as biosynthesized nanoparticles by Fusarium oxysporum extract are urgently needed.. The biosynthesis of silver nanoparticles (AgNPs) as an antibacterial agent against MDR clinical isolates bacteria such as Staphylococcus aureus and Klebsiella pneumonia was determined.

    Bacteria:

    Article Title: Synthesis, antibacterial activity and genotoxicity of silver nanoparticles
    Article Snippet: Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224.

    Article Title: NMR Based Real-Time Analysis of Exometabolites Decodes the Mechanism of Action of Antibacterial Molecules, Nanoparticles, and Materials.
    Article Snippet: 2007, 73 (6), 1712−1720. (55) Raffi, M.; et al. Antibacterial Characterization of Silver Nanoparticles against E. Coli ATCC-15224.

    Article Title: Synthesis of Silver nanoparticles using bioactive seaweeds against poultry pathogens
    Article Snippet: Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224.

    Article Title: Novel Investigative Study on the Anticancer Potential of Plant Extracts and Silver Nanoparticles as Inhibitory Agents for Lung Cancer
    Article Snippet: [34] Raffi, M., Hussain, F., Bhatti, T.M., Akhter, J.I., Hameed, A., and Hasan, M.M., Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224.

    Article Title: Plasmon-based detection of Uric Acid in aqueous solution using colloidal Ag nanoparticles
    Article Snippet: Bhatti, et al. Antibacterial characterization of silver nanoparticles against E.coli ATCC-15224.

    Article Title: Atomic force microscopic investigations of transient early-stage bacterial adhesion and antibacterial activity of silver and ceria modified bioactive glass
    Article Snippet: M. Raffi, F. Hussain, T. Bhatti, J. Akhter, A. Hameed, M. Hasan, Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224.

    Article Title: Antibacterial Effect of Myco-synthesized Nano-silver against Multidrug-resistant Bacteria
    Article Snippet: Multidrug resistance bacteria (MDR) are a serious and increasing public health problem.. For controlling pathogen growth, new strategies such as biosynthesized nanoparticles by Fusarium oxysporum extract are urgently needed.. The biosynthesis of silver nanoparticles (AgNPs) as an antibacterial agent against MDR clinical isolates bacteria such as Staphylococcus aureus and Klebsiella pneumonia was determined.

    Adhesive:

    Article Title: Synthesis, antibacterial activity and genotoxicity of silver nanoparticles
    Article Snippet: Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224.

    Article Title: NMR Based Real-Time Analysis of Exometabolites Decodes the Mechanism of Action of Antibacterial Molecules, Nanoparticles, and Materials.
    Article Snippet: 2007, 73 (6), 1712−1720. (55) Raffi, M.; et al. Antibacterial Characterization of Silver Nanoparticles against E. Coli ATCC-15224.

    Article Title: Synthesis of Silver nanoparticles using bioactive seaweeds against poultry pathogens
    Article Snippet: Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224.

    Article Title: Novel Investigative Study on the Anticancer Potential of Plant Extracts and Silver Nanoparticles as Inhibitory Agents for Lung Cancer
    Article Snippet: [34] Raffi, M., Hussain, F., Bhatti, T.M., Akhter, J.I., Hameed, A., and Hasan, M.M., Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224.

    Article Title: Plasmon-based detection of Uric Acid in aqueous solution using colloidal Ag nanoparticles
    Article Snippet: Bhatti, et al. Antibacterial characterization of silver nanoparticles against E.coli ATCC-15224.

    Article Title: Atomic force microscopic investigations of transient early-stage bacterial adhesion and antibacterial activity of silver and ceria modified bioactive glass
    Article Snippet: M. Raffi, F. Hussain, T. Bhatti, J. Akhter, A. Hameed, M. Hasan, Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224.

    Article Title: Antibacterial Effect of Myco-synthesized Nano-silver against Multidrug-resistant Bacteria
    Article Snippet: Multidrug resistance bacteria (MDR) are a serious and increasing public health problem.. For controlling pathogen growth, new strategies such as biosynthesized nanoparticles by Fusarium oxysporum extract are urgently needed.. The biosynthesis of silver nanoparticles (AgNPs) as an antibacterial agent against MDR clinical isolates bacteria such as Staphylococcus aureus and Klebsiella pneumonia was determined.

    Standard Deviation:

    Article Title: Synthesis, antibacterial activity and genotoxicity of silver nanoparticles
    Article Snippet: Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224.

    Article Title: NMR Based Real-Time Analysis of Exometabolites Decodes the Mechanism of Action of Antibacterial Molecules, Nanoparticles, and Materials.
    Article Snippet: 2007, 73 (6), 1712−1720. (55) Raffi, M.; et al. Antibacterial Characterization of Silver Nanoparticles against E. Coli ATCC-15224.

    Article Title: Synthesis of Silver nanoparticles using bioactive seaweeds against poultry pathogens
    Article Snippet: Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224.

    Article Title: Novel Investigative Study on the Anticancer Potential of Plant Extracts and Silver Nanoparticles as Inhibitory Agents for Lung Cancer
    Article Snippet: [34] Raffi, M., Hussain, F., Bhatti, T.M., Akhter, J.I., Hameed, A., and Hasan, M.M., Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224.

    Article Title: Plasmon-based detection of Uric Acid in aqueous solution using colloidal Ag nanoparticles
    Article Snippet: Bhatti, et al. Antibacterial characterization of silver nanoparticles against E.coli ATCC-15224.

    Article Title: Atomic force microscopic investigations of transient early-stage bacterial adhesion and antibacterial activity of silver and ceria modified bioactive glass
    Article Snippet: M. Raffi, F. Hussain, T. Bhatti, J. Akhter, A. Hameed, M. Hasan, Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224.

    Article Title: Antibacterial Effect of Myco-synthesized Nano-silver against Multidrug-resistant Bacteria
    Article Snippet: Multidrug resistance bacteria (MDR) are a serious and increasing public health problem.. For controlling pathogen growth, new strategies such as biosynthesized nanoparticles by Fusarium oxysporum extract are urgently needed.. The biosynthesis of silver nanoparticles (AgNPs) as an antibacterial agent against MDR clinical isolates bacteria such as Staphylococcus aureus and Klebsiella pneumonia was determined.

    Amplification:

    Article Title: Synthesis, antibacterial activity and genotoxicity of silver nanoparticles
    Article Snippet: Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224.

    Article Title: NMR Based Real-Time Analysis of Exometabolites Decodes the Mechanism of Action of Antibacterial Molecules, Nanoparticles, and Materials.
    Article Snippet: 2007, 73 (6), 1712−1720. (55) Raffi, M.; et al. Antibacterial Characterization of Silver Nanoparticles against E. Coli ATCC-15224.

    Article Title: Synthesis of Silver nanoparticles using bioactive seaweeds against poultry pathogens
    Article Snippet: Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224.

    Article Title: Novel Investigative Study on the Anticancer Potential of Plant Extracts and Silver Nanoparticles as Inhibitory Agents for Lung Cancer
    Article Snippet: [34] Raffi, M., Hussain, F., Bhatti, T.M., Akhter, J.I., Hameed, A., and Hasan, M.M., Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224.

    Article Title: Plasmon-based detection of Uric Acid in aqueous solution using colloidal Ag nanoparticles
    Article Snippet: Bhatti, et al. Antibacterial characterization of silver nanoparticles against E.coli ATCC-15224.

    Article Title: Atomic force microscopic investigations of transient early-stage bacterial adhesion and antibacterial activity of silver and ceria modified bioactive glass
    Article Snippet: M. Raffi, F. Hussain, T. Bhatti, J. Akhter, A. Hameed, M. Hasan, Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224.

    Article Title: Antibacterial Effect of Myco-synthesized Nano-silver against Multidrug-resistant Bacteria
    Article Snippet: Multidrug resistance bacteria (MDR) are a serious and increasing public health problem.. For controlling pathogen growth, new strategies such as biosynthesized nanoparticles by Fusarium oxysporum extract are urgently needed.. The biosynthesis of silver nanoparticles (AgNPs) as an antibacterial agent against MDR clinical isolates bacteria such as Staphylococcus aureus and Klebsiella pneumonia was determined.

    Produced:

    Article Title: Synthesis, antibacterial activity and genotoxicity of silver nanoparticles
    Article Snippet: Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224.

    Article Title: NMR Based Real-Time Analysis of Exometabolites Decodes the Mechanism of Action of Antibacterial Molecules, Nanoparticles, and Materials.
    Article Snippet: 2007, 73 (6), 1712−1720. (55) Raffi, M.; et al. Antibacterial Characterization of Silver Nanoparticles against E. Coli ATCC-15224.

    Article Title: Synthesis of Silver nanoparticles using bioactive seaweeds against poultry pathogens
    Article Snippet: Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224.

    Article Title: Novel Investigative Study on the Anticancer Potential of Plant Extracts and Silver Nanoparticles as Inhibitory Agents for Lung Cancer
    Article Snippet: [34] Raffi, M., Hussain, F., Bhatti, T.M., Akhter, J.I., Hameed, A., and Hasan, M.M., Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224.

    Article Title: Plasmon-based detection of Uric Acid in aqueous solution using colloidal Ag nanoparticles
    Article Snippet: Bhatti, et al. Antibacterial characterization of silver nanoparticles against E.coli ATCC-15224.

    Article Title: Atomic force microscopic investigations of transient early-stage bacterial adhesion and antibacterial activity of silver and ceria modified bioactive glass
    Article Snippet: M. Raffi, F. Hussain, T. Bhatti, J. Akhter, A. Hameed, M. Hasan, Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224.

    Article Title: Antibacterial Effect of Myco-synthesized Nano-silver against Multidrug-resistant Bacteria
    Article Snippet: Multidrug resistance bacteria (MDR) are a serious and increasing public health problem.. For controlling pathogen growth, new strategies such as biosynthesized nanoparticles by Fusarium oxysporum extract are urgently needed.. The biosynthesis of silver nanoparticles (AgNPs) as an antibacterial agent against MDR clinical isolates bacteria such as Staphylococcus aureus and Klebsiella pneumonia was determined.

    Marker:

    Article Title: Synthesis, antibacterial activity and genotoxicity of silver nanoparticles
    Article Snippet: Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224.

    Article Title: NMR Based Real-Time Analysis of Exometabolites Decodes the Mechanism of Action of Antibacterial Molecules, Nanoparticles, and Materials.
    Article Snippet: 2007, 73 (6), 1712−1720. (55) Raffi, M.; et al. Antibacterial Characterization of Silver Nanoparticles against E. Coli ATCC-15224.

    Article Title: Synthesis of Silver nanoparticles using bioactive seaweeds against poultry pathogens
    Article Snippet: Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224.

    Article Title: Novel Investigative Study on the Anticancer Potential of Plant Extracts and Silver Nanoparticles as Inhibitory Agents for Lung Cancer
    Article Snippet: [34] Raffi, M., Hussain, F., Bhatti, T.M., Akhter, J.I., Hameed, A., and Hasan, M.M., Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224.

    Article Title: Plasmon-based detection of Uric Acid in aqueous solution using colloidal Ag nanoparticles
    Article Snippet: Bhatti, et al. Antibacterial characterization of silver nanoparticles against E.coli ATCC-15224.

    Article Title: Atomic force microscopic investigations of transient early-stage bacterial adhesion and antibacterial activity of silver and ceria modified bioactive glass
    Article Snippet: M. Raffi, F. Hussain, T. Bhatti, J. Akhter, A. Hameed, M. Hasan, Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224.

    Article Title: Antibacterial Effect of Myco-synthesized Nano-silver against Multidrug-resistant Bacteria
    Article Snippet: Multidrug resistance bacteria (MDR) are a serious and increasing public health problem.. For controlling pathogen growth, new strategies such as biosynthesized nanoparticles by Fusarium oxysporum extract are urgently needed.. The biosynthesis of silver nanoparticles (AgNPs) as an antibacterial agent against MDR clinical isolates bacteria such as Staphylococcus aureus and Klebsiella pneumonia was determined.

    Control:

    Article Title: Synthesis, antibacterial activity and genotoxicity of silver nanoparticles
    Article Snippet: Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224.

    Article Title: NMR Based Real-Time Analysis of Exometabolites Decodes the Mechanism of Action of Antibacterial Molecules, Nanoparticles, and Materials.
    Article Snippet: 2007, 73 (6), 1712−1720. (55) Raffi, M.; et al. Antibacterial Characterization of Silver Nanoparticles against E. Coli ATCC-15224.

    Article Title: Synthesis of Silver nanoparticles using bioactive seaweeds against poultry pathogens
    Article Snippet: Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224.

    Article Title: Novel Investigative Study on the Anticancer Potential of Plant Extracts and Silver Nanoparticles as Inhibitory Agents for Lung Cancer
    Article Snippet: [34] Raffi, M., Hussain, F., Bhatti, T.M., Akhter, J.I., Hameed, A., and Hasan, M.M., Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224.

    Article Title: Plasmon-based detection of Uric Acid in aqueous solution using colloidal Ag nanoparticles
    Article Snippet: Bhatti, et al. Antibacterial characterization of silver nanoparticles against E.coli ATCC-15224.

    Article Title: Atomic force microscopic investigations of transient early-stage bacterial adhesion and antibacterial activity of silver and ceria modified bioactive glass
    Article Snippet: M. Raffi, F. Hussain, T. Bhatti, J. Akhter, A. Hameed, M. Hasan, Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224.

    Article Title: Antibacterial Effect of Myco-synthesized Nano-silver against Multidrug-resistant Bacteria
    Article Snippet: Multidrug resistance bacteria (MDR) are a serious and increasing public health problem.. For controlling pathogen growth, new strategies such as biosynthesized nanoparticles by Fusarium oxysporum extract are urgently needed.. The biosynthesis of silver nanoparticles (AgNPs) as an antibacterial agent against MDR clinical isolates bacteria such as Staphylococcus aureus and Klebsiella pneumonia was determined.



    Similar Products

    95
    ATCC silver nanoparticles against e coli atcc
    Silver Nanoparticles Against E Coli Atcc, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/silver+nanoparticles+against+e+coli+atcc/Escherichia+coli/pm41730123-423-12-17
    Average 95 stars, based on 1 article reviews
    silver nanoparticles against e coli atcc - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    99
    ATCC apramycin silver nanoparticles against e coli atcc 25922 well
    Apramycin Silver Nanoparticles Against E Coli Atcc 25922 Well, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/silver+nanoparticles+against+e+coli+atcc/Escherichia+coli+(Migula)+Castellani+and+Chalmers/pmc12368801__NA-007-D5NA00404G-s001-56-21-28
    Average 99 stars, based on 1 article reviews
    apramycin silver nanoparticles against e coli atcc 25922 well - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    99
    ATCC apramycin silver nanoparticles against e coli atcc 25922
    Apramycin Silver Nanoparticles Against E Coli Atcc 25922, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/silver+nanoparticles+against+e+coli+atcc/Escherichia+coli+(Migula)+Castellani+and+Chalmers/pmc12368801__NA-007-D5NA00404G-s001-15-21-28
    Average 99 stars, based on 1 article reviews
    apramycin silver nanoparticles against e coli atcc 25922 - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    99
    ATCC silver nanoparticles against e coli atcc 25922
    Bacteriostatic effects of antimicrobial combinations against <t>E.</t> <t>coli</t> ATCC 25922: (a) apramycin–silver( i ) and (b) apramycin–silver nanoparticles. Absence of turbidity: grey. Presence of turbidity: white. Synergism: S. Indifference: I.
    Silver Nanoparticles Against E Coli Atcc 25922, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/silver+nanoparticles+against+e+coli+atcc/Escherichia+coli+(Migula)+Castellani+and+Chalmers/pmc12368801-188-22-27
    Average 99 stars, based on 1 article reviews
    silver nanoparticles against e coli atcc 25922 - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    Image Search Results


    Bacteriostatic effects of antimicrobial combinations against E. coli ATCC 25922: (a) apramycin–silver( i ) and (b) apramycin–silver nanoparticles. Absence of turbidity: grey. Presence of turbidity: white. Synergism: S. Indifference: I.

    Journal: Nanoscale Advances

    Article Title: Synergistic activity of silver nanoparticles and antibiotics: apramycin against Escherichia coli

    doi: 10.1039/d5na00404g

    Figure Lengend Snippet: Bacteriostatic effects of antimicrobial combinations against E. coli ATCC 25922: (a) apramycin–silver( i ) and (b) apramycin–silver nanoparticles. Absence of turbidity: grey. Presence of turbidity: white. Synergism: S. Indifference: I.

    Article Snippet: To the best of authors' knowledge, this is the first study to evaluate the combination of apramycin with silver( i ) and silver nanoparticles against E. coli ATCC 25922.

    Techniques:

    Bactericidal effects of antimicrobial combinations against E. coli ATCC 25922: (a) apramycin–silver( i ) and (b) apramycin–silver nanoparticles. Absence of turbidity: grey. Presence of turbidity: white. Synergism: S. Indifference: I. *: bacterial growth.

    Journal: Nanoscale Advances

    Article Title: Synergistic activity of silver nanoparticles and antibiotics: apramycin against Escherichia coli

    doi: 10.1039/d5na00404g

    Figure Lengend Snippet: Bactericidal effects of antimicrobial combinations against E. coli ATCC 25922: (a) apramycin–silver( i ) and (b) apramycin–silver nanoparticles. Absence of turbidity: grey. Presence of turbidity: white. Synergism: S. Indifference: I. *: bacterial growth.

    Article Snippet: To the best of authors' knowledge, this is the first study to evaluate the combination of apramycin with silver( i ) and silver nanoparticles against E. coli ATCC 25922.

    Techniques:

    Silver mass per bacteria distributions analysed by SC-ICP-MS for samples of E. coli ATCC 25922 bacteria exposed to: (a) 0.50 mg L −1 Ag( i ), (b) 0.50 mg L −1 Ag( i ) + 0.25 mg L −1 apramycin and (c) 0.50 mg L −1 Ag( i ) + 2 mg L −1 apramycin.

    Journal: Nanoscale Advances

    Article Title: Synergistic activity of silver nanoparticles and antibiotics: apramycin against Escherichia coli

    doi: 10.1039/d5na00404g

    Figure Lengend Snippet: Silver mass per bacteria distributions analysed by SC-ICP-MS for samples of E. coli ATCC 25922 bacteria exposed to: (a) 0.50 mg L −1 Ag( i ), (b) 0.50 mg L −1 Ag( i ) + 0.25 mg L −1 apramycin and (c) 0.50 mg L −1 Ag( i ) + 2 mg L −1 apramycin.

    Article Snippet: To the best of authors' knowledge, this is the first study to evaluate the combination of apramycin with silver( i ) and silver nanoparticles against E. coli ATCC 25922.

    Techniques: Bacteria

    Silver mass per bacteria distributions analysed by SC-ICP-MS for samples of E. coli ATCC 25922 bacteria exposed to: (a) 2 mg L −1 AgNPs, (b) 2 mg L −1 AgNPs + 0.25 mg L −1 apramycin and (c) 2 mg L −1 AgNPs + 2 mg L −1 apramycin.

    Journal: Nanoscale Advances

    Article Title: Synergistic activity of silver nanoparticles and antibiotics: apramycin against Escherichia coli

    doi: 10.1039/d5na00404g

    Figure Lengend Snippet: Silver mass per bacteria distributions analysed by SC-ICP-MS for samples of E. coli ATCC 25922 bacteria exposed to: (a) 2 mg L −1 AgNPs, (b) 2 mg L −1 AgNPs + 0.25 mg L −1 apramycin and (c) 2 mg L −1 AgNPs + 2 mg L −1 apramycin.

    Article Snippet: To the best of authors' knowledge, this is the first study to evaluate the combination of apramycin with silver( i ) and silver nanoparticles against E. coli ATCC 25922.

    Techniques: Bacteria

    Percentage of silver-containing bacteria E. coli ATCC 25922 in relation to total bacteria. Exposed silver concentration: 0.50 mg L −1 Ag( i ) and 2 mg L −1 10 nm AgNPs.

    Journal: Nanoscale Advances

    Article Title: Synergistic activity of silver nanoparticles and antibiotics: apramycin against Escherichia coli

    doi: 10.1039/d5na00404g

    Figure Lengend Snippet: Percentage of silver-containing bacteria E. coli ATCC 25922 in relation to total bacteria. Exposed silver concentration: 0.50 mg L −1 Ag( i ) and 2 mg L −1 10 nm AgNPs.

    Article Snippet: To the best of authors' knowledge, this is the first study to evaluate the combination of apramycin with silver( i ) and silver nanoparticles against E. coli ATCC 25922.

    Techniques: Bacteria, Concentration Assay

    SEM images (10000×) of E. coli ATCC 25922: (a) control and exposed to (b) 2 mg L −1 apramycin, (c) 2 mgL −1 10 nm AgNPs and (d) 2 mg L −1 apramycin + 2 mg L −1 10 nm AgNPs.

    Journal: Nanoscale Advances

    Article Title: Synergistic activity of silver nanoparticles and antibiotics: apramycin against Escherichia coli

    doi: 10.1039/d5na00404g

    Figure Lengend Snippet: SEM images (10000×) of E. coli ATCC 25922: (a) control and exposed to (b) 2 mg L −1 apramycin, (c) 2 mgL −1 10 nm AgNPs and (d) 2 mg L −1 apramycin + 2 mg L −1 10 nm AgNPs.

    Article Snippet: To the best of authors' knowledge, this is the first study to evaluate the combination of apramycin with silver( i ) and silver nanoparticles against E. coli ATCC 25922.

    Techniques: Control

    TEM images (250 00×–100 000×) of bacteria E. coli ATCC 25922: (a) control and exposed to (b) 2 mg L −1 apramycin, (c and d) 2 mg L −1 10 nm AgNPs, and (e and f) 2 mg L −1 10 nm AgNPs + 2 mg L -1 apramycin. Red arrows: shrinkage and heterogeneity of the cytoplasm. Red circles: membrane rupture and cytoplasm leakage.

    Journal: Nanoscale Advances

    Article Title: Synergistic activity of silver nanoparticles and antibiotics: apramycin against Escherichia coli

    doi: 10.1039/d5na00404g

    Figure Lengend Snippet: TEM images (250 00×–100 000×) of bacteria E. coli ATCC 25922: (a) control and exposed to (b) 2 mg L −1 apramycin, (c and d) 2 mg L −1 10 nm AgNPs, and (e and f) 2 mg L −1 10 nm AgNPs + 2 mg L -1 apramycin. Red arrows: shrinkage and heterogeneity of the cytoplasm. Red circles: membrane rupture and cytoplasm leakage.

    Article Snippet: To the best of authors' knowledge, this is the first study to evaluate the combination of apramycin with silver( i ) and silver nanoparticles against E. coli ATCC 25922.

    Techniques: Bacteria, Control, Membrane